Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 10
2012 12
2013 6
2014 3
2015 1
2016 1
2022 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Response to Interleukin-1 Blockade With Anakinra in Black and White Americans With ST-Segment Elevation Myocardial Infarction.
Corna G, Golino M, Moroni F, Del Buono MG, Talasaz AH, Decotto S, Mbualungu J, Trankle CR, Thomas GK, Markley R, Canada JM, Turlington J, Agatiello CR, Keen L, Van Tassell B, Abbate A. Corna G, et al. Am J Cardiol. 2023 Nov 15;207:336-338. doi: 10.1016/j.amjcard.2023.08.175. Epub 2023 Sep 27. Am J Cardiol. 2023. PMID: 37774475 No abstract available.
Differential Response to Interleukin-1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction.
Golino M, Moroni F, Carbone S, Corna G, Trankle C, Billingsley HE, Del Buono MG, Talasaz AH, Thomas GK, De Ponti R, Turlington J, Markley R, Arena R, Canada JM, Van Tassell B, Abbate A. Golino M, et al. J Am Heart Assoc. 2023 Sep 19;12(18):e031251. doi: 10.1161/JAHA.123.031251. Epub 2023 Sep 18. J Am Heart Assoc. 2023. PMID: 37624043 Free PMC article. No abstract available.
Clinical and Pharmacological Implications of Time to Treatment with Interleukin-1 Blockade in ST-Segment Elevation Myocardial Infarction.
Del Buono MG, Damonte JI, Moroni F, Chiabrando JG, Markley R, Turlington J, Trankle CR, Kang L, Biondi-Zoccai G, Kontos MC, Roberts CS, Van Tassell BW, Abbate A. Del Buono MG, et al. J Pharmacol Exp Ther. 2023 Aug;386(2):156-163. doi: 10.1124/jpet.123.001601. Epub 2023 Apr 10. J Pharmacol Exp Ther. 2023. PMID: 37037651
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials.
Abbate A, Wohlford GF, Del Buono MG, Chiabrando JG, Markley R, Turlington J, Kadariya D, Trankle CR, Biondi-Zoccai G, Lipinski MJ, Van Tassell BW. Abbate A, et al. Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):503-510. doi: 10.1093/ehjcvp/pvab075. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34617567 Free PMC article.
Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study).
Van Tassell BW, Arena R, Biondi-Zoccai G, Canada JM, Oddi C, Abouzaki NA, Jahangiri A, Falcao RA, Kontos MC, Shah KB, Voelkel NF, Dinarello CA, Abbate A. Van Tassell BW, et al. Am J Cardiol. 2014 Jan 15;113(2):321-327. doi: 10.1016/j.amjcard.2013.08.047. Epub 2013 Oct 4. Am J Cardiol. 2014. PMID: 24262762 Free PMC article. Clinical Trial.
35 results